FeaturesSignalPricingFounders
PM

Penn Medicine Co-Investment Fund

Venture CapitalModerate

Penn Medicine Co-Investment Fund is an investment Fund.

Philadelphia, United StatesFounded 2018
9
Investments
1
Exits
—
AUM
11.1%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Penn Medicine Co-Investment Fund.

Get started free

Investment Thesis & Strategy

Penn Medicine Co-Investment Fund invests in various stages of biopharma, biotech, healthcare, and life science companies. The fund likely seeks companies with strong potential for medical advancements and alignment with the University of Pennsylvania's medical research.

Investment Activity

Deals per year over the last 5 years

1
2019
0
2020
5
2021
4
2022
2
2023

Portfolio Companies

Selected investments from their portfolio of 9 companies

R
Replay
Biotech · Series A, 2023
Active
C
Cellino Biotech
Biotech · Series A, 2023
Active
G
Gradient Health
Healthcare · Series A, 2022
Active
J
Jasper Therapeutics
Biotech · Series B, 2022
Active
V
Vytalize Health
Healthcare · Growth, 2022
Active
B
BioAge Labs
Biotech · Series B, 2022
Active
G
Generate Biomedicines
Biotech · Series B, 2021
Active
A
Aura Biosciences
Biotech · Series B, 2021
Active
T
Tessera Therapeutics
Biotech · Series B, 2021
Active
C
Caribou Biosciences
Biotech · Series B, 2021
Active
L
LifeMine Therapeutics
Biotech · Series B, 2021
Active
M
Mindstrong Health
Healthcare · Series B, 2019
Active

Frequently Asked Questions

Penn Medicine Co-Investment Fund focuses on Series A, Series B, Series C+ stage investments.

Related Investors

EnerTech Capital

Philadelphia, United States · 71 deals

Quaker BioVentures

Philadelphia, United States · 54 deals

MissionOG

Philadelphia, United States · 42 deals

Karlani Capital

Philadelphia, United States · 23 deals

Quaker Partners

Philadelphia, United States · 15 deals

Gabriel Investments

Philadelphia, United States · 11 deals